Expert consensus on clinical management of metabolic bone disease of prematurity (2021) / 中国当代儿科杂志
Chinese Journal of Contemporary Pediatrics
; (12): 761-772, 2021.
Article
in En
| WPRIM
| ID: wpr-888479
Responsible library:
WPRO
ABSTRACT
Metabolic bone disease of prematurity (MBDP) is a systemic bone disease with a reduction in bone mineral content due to disorder of calcium and phosphorus metabolism. There is still a lack of in-depth research and systematic understanding of MBDP in China, and there are many irregularities in clinical management of this disease. Based on relevant studies in China and overseas, Grading of Recommendations Assessment, Development and Evaluation was used to develop the expert consensus on the clinical management of MBDP, which provides recommendations from the following five aspects: high-risk factors, screening/diagnosis, prevention, treatment, and post-discharge follow-up of MBDP, so as to provide relevant practitioners with recommendations on the clinical management of MBDP to reduce the incidence rate of MBDP and improve its short- and long-term prognosis.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Patient Discharge
/
Bone Diseases, Metabolic
/
Infant, Premature
/
Aftercare
/
Consensus
Type of study:
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
/
Newborn
Language:
En
Journal:
Chinese Journal of Contemporary Pediatrics
Year:
2021
Type:
Article